Biography
Dr. Shen Song is a distinguished Director of Radiation Oncology at Shanghai Children's Medical Center with 24 years of dedicated clinical practice. Over the course of an extensive career, Shen Song has treated thousands of international and domestic patients, establishing a reputation for clinical excellence, evidence-based decision-making, and compassionate, family-centered care.
Clinical Focus & Expertise
Dr. Shen Song specializes in the diagnosis and management of complex medical conditions, with particular expertise in Breast cancer, CAR-T cell therapy, Hepatocellular carcinoma, Immunotherapy. The clinical practice combines current best-evidence medicine with personalized treatment planning — recognizing that every patient brings a unique medical history, lifestyle, and set of life priorities to the consultation room.
Conditions Treated
Patients consult Dr. Shen Song for the following conditions and procedures:
- Breast cancer
- CAR-T cell therapy
- Hepatocellular carcinoma
- Immunotherapy
Education & Training
- MD Zhejiang University · Fellowship Memorial Sloan Kettering
Professional Credentials & Memberships
- Chinese Society of Clinical Oncology Member
- European Society for Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer
International Patient Care
Dr. Shen Song communicates with patients in English, Chinese, Japanese, providing direct rapport without the need for translation in those languages. The hospital's international department coordinates dedicated case managers, multilingual interpreters for additional languages, simplified visa documentation, and personalized treatment itineraries for travelers from over 60 countries.
“Every patient deserves more than a diagnosis — they deserve a treatment plan that respects who they are, where they come from, and what matters most to them.”
Education
MD Zhejiang University · Fellowship Memorial Sloan Kettering
Certifications
- Chinese Society of Clinical Oncology Member
- European Society for Medical Oncology (ESMO)
- International Association for the Study of Lung Cancer